Arcus Biosciences to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the upcoming Goldman Sachs 44th Annual Global Healthcare Conference at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, California. The fireside chat will take place on Tuesday, June 13th, 2023 at 4 p.m. PT.

A live webcast of the fireside chat will be available by visiting the “Investors & Media” section of the Arcus Biosciences website at www.arcusbio.com. A replay of the webcast will be available following the live event.

About Arcus Biosciences

Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of multiple investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b receptor) and most recently, HIF-2a. For more information about Arcus Biosciences’ clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230530005001/en/

Media Inquiries
Holli Kolkey
VP of Corporate Communications
(650) 922-1269
[email protected]

Investor Inquiries
Pia Banerjee
Head of Investor Relations & Strategy
(617) 459-2006
[email protected]

Source: Arcus Biosciences

You May Also Be Interested In

• Mativ Announces Appointment of New Chair of its Board of Directors
• TOYOTA NAMED OFFICIAL VEHICLES OF WORLD WIDE TECHNOLOGY RACEWAY
• Ensurge Micropower ASA - Grant of Incentive Subscription Rights